MRNA vs RVMD
Moderna, Inc. - Common Stock · Revolution Medicines, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | MRNA | RVMD |
|---|---|---|
| Price | $174.38 | $214.66 |
| Market Cap | $69.19B | $45.64B |
| P/E | — | — |
| P/B | 9.34 | 30.43 |
| P/S | 35.59 | — |
| ROE | -38.1% | -75.4% |
| Net Margin | -145.2% | — |
| Gross Margin | — | — |
| Revenue Growth | -39.9% | — |
| Dividend Yield | — | — |
| EPS | -$7.11 | -$5.32 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.